Chapman, M. J. and Packard, C. J. (2023) Realizing the potential of PCSK9 inhibition: a novel oral macrocyclic peptide on the horizon. Journal of the American College of Cardiology, 81(16), pp. 1565-1568. (doi: 10.1016/j.jacc.2023.03.384) (PMID:37076210)
![[img]](https://eprints.gla.ac.uk/style/images/fileicons/text.png) |
Text
296849.pdf - Accepted Version Available under License Creative Commons Attribution Non-commercial No Derivatives. 380kB |
Abstract
No abstract available.
| Item Type: | Articles (Editorial) |
|---|---|
| Status: | Published |
| Refereed: | Yes |
| Glasgow Author(s) Enlighten ID: | Packard, Professor Chris |
| Authors: | Chapman, M. J., and Packard, C. J. |
| College/School: | College of Medical Veterinary and Life Sciences > School of Cardiovascular & Metabolic Health |
| Journal Name: | Journal of the American College of Cardiology |
| Publisher: | Elsevier |
| ISSN: | 0735-1097 |
| ISSN (Online): | 1558-3597 |
| Published Online: | 17 April 2023 |
| Copyright Holders: | Copyright © 2023 Elsevier |
| First Published: | First published in Journal of the American College of Cardiology 81(16):1565-1568 |
| Publisher Policy: | Reproduced in accordance with the copyright policy of the publisher |
University Staff: Request a correction | Enlighten Editors: Update this record
Deposit and Record Details
Deposit and Record Details